Search by Drug Name or NDC

    NDC 69097-0876-12 Bupropion Hydrochloride 300 mg/1 Details

    Bupropion Hydrochloride 300 mg/1

    Bupropion Hydrochloride is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by CIPLA USA INC.,. The primary component is BUPROPION HYDROCHLORIDE.

    Product Information

    NDC 69097-0876
    Product ID 69097-876_6fb20e45-74e9-4038-9db0-9eaf24b5560a
    Associated GPIs 58300040107530
    GCN Sequence Number 053007
    GCN Sequence Number Description bupropion HCl TAB ER 24H 300 MG ORAL
    HIC3 H7D
    HIC3 Description NOREPINEPHRINE AND DOPAMINE REUPTAKE INHIB (NDRIS)
    GCN 20318
    HICL Sequence Number 001653
    HICL Sequence Number Description BUPROPION HCL
    Brand/Generic Generic
    Proprietary Name Bupropion Hydrochloride
    Proprietary Name Suffix (XL)
    Non-Proprietary Name bupropion hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name BUPROPION HYDROCHLORIDE
    Labeler Name CIPLA USA INC.,
    Pharmaceutical Class Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA206556
    Listing Certified Through 2024-12-31

    Package

    NDC 69097-0876-12 (69097087612)

    NDC Package Code 69097-876-12
    Billing NDC 69097087612
    Package 500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69097-876-12)
    Marketing Start Date 2016-08-29
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.16239
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description BUPROPION HCL XL 300 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL c2cf79d7-1aba-4391-980b-5e218781f7c6 Details

    Revised: 4/2020